Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Jan 2003 04:47 PM
RNS
Holding(s) in Company
06 Jan 2003 07:00 AM
RNS
Research Agreement
17 Dec 2002 11:43 AM
RNS
Grant Awarded
25 Nov 2002 07:00 AM
RNS
Change of Adviser
14 Nov 2002 10:47 AM
RNS
New Appointment
08 Nov 2002 09:00 AM
RNS
Update on Clinical Plans
01 Nov 2002 02:12 PM
RNS
Directorate Change
24 Oct 2002 08:59 AM
RNS
New Development Partner
19 Sep 2002 03:02 PM
RNS
Director Shareholding
17 Sep 2002 12:16 PM
RNS
Director Shareholding
11 Sep 2002 03:26 PM
RNS
Director Shareholding
29 Aug 2002 03:35 PM
RNS
Director Shareholding
28 Aug 2002 07:00 AM
RNS
Interim Results
27 Aug 2002 04:10 PM
RNS
Holding(s) in Company
13 Aug 2002 11:28 AM
RNS
Notice of Results
06 Aug 2002 03:48 PM
RNS
Holding(s) in Company
25 Jul 2002 09:23 AM
RNS
Re Agreement
11 Jul 2002 07:00 AM
RNS
Positive Clinical Trials
27 Jun 2002 03:10 PM
RNS
Holding(s) in Company
25 Jun 2002 07:00 AM
RNS
Research Update
10 Jun 2002 07:00 AM
RNS
Research Update
06 Jun 2002 07:00 AM
RNS
Statement re: product update
08 May 2002 07:00 AM
RNS
Re Alliance
01 May 2002 11:57 AM
RNS
Directorate Change
20 Mar 2002 04:08 PM
RNS
Annual Report & Accts etc
27 Feb 2002 07:00 AM
RNS
Final Results
20 Feb 2002 02:30 PM
RNS
Research Update
22 Jan 2002 11:09 AM
RNS
Blocklisting Interim Review
15 Jan 2002 02:57 PM
RNS
Notice of Results
24 Dec 2001 11:57 AM
RNS
Director Shareholding
13 Dec 2001 07:00 AM
RNS
Research Update/Issue of Shrs
12 Nov 2001 07:00 AM
RNS
Research Update
01 Nov 2001 02:52 PM
RNS
Director Shareholding
15 Oct 2001 07:00 AM
RNS
Research Update
02 Oct 2001 11:00 AM
RNS
Termination of collaboration
12 Sep 2001 09:34 AM
RNS
Holding in Company
06 Sep 2001 10:31 AM
RNS
Hldg in Co/D. Shareholding
01 Aug 2001 07:01 AM
RNS
Interim Results
27 Jul 2001 04:39 PM
RNS
Notice of Results
10 Jul 2001 10:41 AM
RNS
Research Update
26 Jun 2001 01:44 PM
RNS
Statement re Patent
29 May 2001 05:28 PM
RNS
Holding in Company
29 May 2001 02:19 PM
RNS
Director Shareholding
29 May 2001 01:09 PM
RNS
Appointment
02 May 2001 05:56 PM
RNS
Additional Listing
24 Apr 2001 11:02 AM
RNS
Re Techmark Index
17 Apr 2001 04:20 PM
RNS
Completion of Fund Raising
17 Apr 2001 01:55 PM
RNS
Document regarding Listing Particulars
17 Apr 2001 07:00 AM
RNS
Results of EGM &Equity Issues
27 Mar 2001 07:00 AM
RNS
Successful patent application

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings